The role of nanomedicine in the imaging and therapy of thrombosis

Nanomedicine

Volumn 6, Issue 8, 2011, Pages 1291-1293

  McCarthy, Jason R ^a   Jaffer, Farouc A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

imaging; iron oxiD.E.; therapy; thrombolysis; thrombosis

Indexed keywords

ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 13A; FIBRIN; FIBRINOLYTIC AGENT; GELATINASE B; NANOPARTICLE; RECOMBINANT PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

BRAIN HEMORRHAGE; DEEP VEIN THROMBOSIS; DRUG EFFICACY; ENZYME ACTIVITY; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; IMAGING; MACROPHAGE; NANOMEDICINE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; STROKE; THROMBOSIS; VASCULAR ENDOTHELIUM;

HUMANS; NANOMEDICINE; NANOPARTICLES; NANOSTRUCTURES; NANOTECHNOLOGY; THROMBOSIS;

EID: 80155125228     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.128     Document Type: Review

References (13)

1. Lanza GM, Wallace KD, Scott MJ et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 94, 3334-3340 (1996).
2. Flacke S, Fischer S, Scott MJ et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 104, 1280-1285 (2001).
3. Yu X, Song SK, Chen J et al. High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn. Reson. Med. 44, 867-872 (2000).
4. McCarthy JR, Patel P, Botnaru I, Haghayeghi P, Weissleder R, Jaffer FA. Multimodal nanoagents for the detection of intravascular thrombi. Bioconjug. Chem. 20, 1251-1255 (2009).
5. Jaffer FA, Tung CH, Wykrzykowska JJ et al. Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi. Circulation 110, 170-176 (2004).
6. Ripplinger CM, Li C, Kim J, McCarthy JR, Lin CP, Jaffer FA. Multispectral in vivo molecular, functional, and anatomical imaging of venous thrombosis resolution. Arterioscleros. Throm. Vasc. Biol. 30, E183-E321 (2010).
7. Anderson HV, Willerson JT. Thrombolysis in acute myocardial infarction. N. Engl. J. Med. 329, 703-709 (1993).
8. Armstrong PW, Collen D. Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1. Circulation 103, 2862-2866 (2001).
9. No authors listed. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N. Engl. J. Med. 333, 1581-1587 (1995).
10. Bi F, Zhang J, Su Y, Tang YC, Liu JN. Chemical conjugation of urokinase to magnetic nanoparticles for targeted thrombolysis. Biomaterials 30, 5125-5130 (2009).
11. Ma YH, Wu SY, Wu T, Chang YJ, Hua MY, Chen JP. Magnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticles. Biomaterials 30, 3343-3351 (2009).
12. Marsh JN, Senpan A, Hu G et al. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis. Nanomedicine (Lond.) 2, 533-543 (2007).
13. Marsh JN, Hu G, Scott MJ et al. A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke. Nanomedicine (Lond.) 6, 605-615 (2011).